FIELD: medicine.
SUBSTANCE: present group of inventions refers to medicine, namely to psychiatry, and concerns treating residual psychosis symptoms. That is ensured by administering an effective amount of a compound of formula I, including a long-acting injectable composition.
EFFECT: invention provides effective treatment of residual negative psychosis symptoms.
31 cl, 11 ex, 3 tbl, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| ORGANIC COMPOUNDS | 2018 |
|
RU2780002C2 |
| ORGANIC COMPOUNDS | 2018 |
|
RU2777366C2 |
| ORGANIC COMPOUNDS | 2011 |
|
RU2591194C2 |
| ORGANIC COMPOUNDS | 2017 |
|
RU2733975C2 |
| ORGANIC COMPOUNDS | 2015 |
|
RU2785871C2 |
| ORGANIC COMPOUNDS | 2015 |
|
RU2728787C2 |
| ORGANIC COMPOUNDS | 2017 |
|
RU2743513C2 |
| PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT OR PREVENTION OF DISORDER OF CENTRAL NERVOUS SYSTEM | 2017 |
|
RU2776800C2 |
| 4-ALKOXYPYRIDAZINE DERIVATIVES AS FAST DISSOCIATING DOPAMINE 2 RECEPTOR ANTAGONISTS | 2008 |
|
RU2464268C2 |
| PYRIDINE DERIVATIVES USED AS QUICKLY DISSOCIABLE DOPAMINE RECEPTOR 2 ANTAGONISTS | 2008 |
|
RU2480462C2 |
